[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100613270":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":53,"collaborators":20,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":62,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":20,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":38,"whyStopped":20,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"University Hospital, Clermont-Ferrand","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Assessment of cardiorespiratory function","EXPERIMENTAL","A Holter ECG and oximetry recording will be performed on the child's second night for a minimum of 6 hours. Three electrodes will be placed on the newborn's chest, along with a pulse oximeter, and removed the following day.\n\nParents will be contacted by email at the child's second birthday to obtain information on their child's height and weight growth, and their neurodevelopment will be assessed using the Age and Stage Questionnaire (ASQ-3) at 24 months.",[13,14],"Other: Heart rate variability","Other: Pulmonary function",[16,21],{"type":6,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"Heart rate variability","A Holter ECG recording will be performed on the child's second night for a minimum of 6 hours.",[9],null,{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":20},"Pulmonary function","Oximetry recording will be performed on the child's second night for a minimum of 6 hours.",[9],[26],{"name":27,"affiliation":5,"role":28},"Justine Paysal","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":20,"email":34},"Lise Laclautre","CONTACT","+33473754963","promo_interne_drci@chu-clermontferrand.fr",[36],{"facility":37,"status":38,"city":39,"state":20,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"CHU de Clermont-Ferrand","RECRUITING","Clermont-Ferrand","63000","France","FR",{"type":44,"coordinates":45},"Point",[46,47],3.08682,45.77969,{"lat":47,"lon":46},[50,51],{"name":31,"role":32,"phone":33,"phoneExt":20,"email":34},{"name":52,"role":28,"phone":20,"phoneExt":20,"email":20},"Justine PAYSAL",{"type":54,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100613270","impact-of-physical-activity-during-pregnancy-on-cardiac-variability-in-newborns-100613270",false,"NCT07264400","Impact of Physical Activity During Pregnancy on Cardiac Variability in Newborns","NEOMOUV","Inclusion Criteria:\n\n* All newborns of mothers who participated in the PregMouv study and who have at least one piece of data for the main criterion from the PregMouv study (physical activity at T1\u002FT2),\n* born at the Clermont Ferrand University Hospital and after parental agreement for their child to participate may be included.\n\nExclusion Criteria:\n\n* Newborns requiring aminergic support in the first days of life,\n* making heart rate variability analysis impossible,\n* having received invasive ventilatory support that does not allow analysis of the oximetry recording.\n* Parental refusal or inability of parents to give their consent for their child to participate.",true,"ALL","1 Day","3 Days",{"count":67,"type":68},100,"ESTIMATED","INTERVENTIONAL",[71],"NA","Ancillary study of the PregMouv study which aims to evaluate an intervention allowing the best adherence of women in terms of physical activity. Several types of interventions are therefore planned in this study: no intervention, physical activity sessions in person, by videoconference or mixed (in person and videoconference) with accelerometer assessment of the level of physical activity practiced (in the form of energy expenditure, in MET). Thus, for our ancillary study, a comparison of the cardiac variability of newborns will be carried out according to the level of physical activity practiced by the mother regardless of the intervention she benefited from within the framework of the PregMouv study. A comparison of the average saturation and the time spent below 90% saturation will be carried out via a continuous recording of saturation by oximetry. A longitudinal follow-up for the assessment of height and weight growth (from growth curves) and neurodevelopment (by clinical examination and self-questionnaire) is also planned until the child is 2 years old.",[74],"Newborn Infant",[76,77],"heart rate variability","oximetry","2025-12-02",{"date":80,"type":81},"2025-12-04","ACTUAL",{"date":83,"type":81},"2025-10-15",{"date":85,"type":68},"2029-04",{"name":5,"class":6},1]